Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

flutamide

View Patient Information
A toluidine derivative and nonsteroidal antiandrogen that is structurally related to bicalutamide and nilutamide. Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively block dihydrotestosterone binding at androgen receptors, forming inactive complexes which cannot translocate into the cell nucleus. Formation of inactive receptors inhibits androgen-dependent DNA and protein synthesis, resulting in tumor cell growth arrest or transient tumor regression.
Synonym:Flucinom
Flugerel
Niftolide
Foreign brand name:Apimid
Cebatrol
Chimax
Cytomid
Drogenil
Euflex
Eulexine
Flucinome
Fluken
Flulem
Fluta-Gry
Flutabene
Flutacan
Flutamex
Flutamin
Flutan
Flutaplex
Fugerel
Grisetin
Oncosal
Profamid
Prostacur
Prostadirex
Prostica
Prostogenat
Tafenil
Tecnoflut
Testotard
Abbreviation:FLUT
Code name:Sch 13521
Chemical structure:2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
4'-nitro-3'-trifluoromethylisobutyranilide
alpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide
IND number:25378
NSC code:147834
215876
Search NCI's Drug Dictionary